SAVA is risky and somewhat controversial. It's about Alzheimer's treatment and that is going to be controversial. Even today Class action suits have been launched for those who bought after the July run up and crash. The momentum could carry it back to the 100+ range but it could be prone to wicked drops. The daily has been reliable and the strategy tester on the daily signal is 500% +. It produced a daily buy today.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.